activating silent biosynthetic gene clusters

Cryptyx Bioscience is a drug discovery company in Princeton, NJ whose platform provides a rapid, efficient approach for activating silent biosynthetic gene clusters and unearthing potential leads that cannot be accessed with extant technologies. The platform does not require complex genetic, cloning, or culturing procedures, can be used with sequenced and unsequenced bacteria, and reports on the bioactivity of cryptic metabolites. The company is advancing novel therapies for bacterial and viral pathogens and expanding R&D to oncology.

Read more

drug discovery platformhigh throughput screeningHiTES platformmicrobial culture growth and maintenancenatural product isolation and structure elucidationphenotypic biological assays